✦ LIBER ✦

Coexistence of a JAK2 Mutated Clone May Cause Hematologic Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

✍ Scribed by Fava, Carmen; Cambrin, Giovanna Rege; Ferrero, Dario; Ulisciani, Stefano; Serra, Anna

Book ID: 119936165
Publisher: CIG Media Group, LP.
Year: 2009
Tongue: English
Weight: 45 KB
Volume: 9
Category: Article
ISSN: 1557-9190
DOI: 10.3816/clm.2009.n.102

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mechanisms of resistance to tyrosine kin

Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance

✍ Bixby, D.; Talpaz, M. 📂 Article 📅 2009 🏛 American Society of Hematology 🌐 English ⚖ 280 KB

Frequency of ABL gene mutations in chron

Frequency of ABL gene mutations in chronic myeloid leukemia patients resistant to imatinib and results of treatment switch to second-generation tyrosine kinase inhibitors

✍ Marcé, Silvia; Zamora, Lurdes; Cabezón, Marta; Xicoy, Blanca; Boqué, Concha; Fer 📂 Article 📅 2013 🏛 Elsevier Science 🌐 Spanish ⚖ 267 KB

Threshold Levels of ABL Tyrosine Kinase

Threshold Levels of ABL Tyrosine Kinase Inhibitors Retained in Chronic Myeloid Leukemia Cells Determine Their Commitment to Apoptosis

✍ O'Hare, T.; Eide, C. A.; Agarwal, A.; Adrian, L. T.; Zabriskie, M. S.; MacKenzie 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 988 KB

Towards a need to a “biological Sokal ri

Towards a need to a “biological Sokal risk” in the era of tyrosine kinase inhibitors in choosing front-line therapy in chronic myeloid leukemia

✍ Fabio Stagno; Paolo Vigneri; Francesco Di Raimondo 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 100 KB

Discontinuation of tyrosine kinase inhib

Discontinuation of tyrosine kinase inhibitors and new approaches to target leukemic stem cells: Treatment-free remission as a new goal in chronic myeloid leukemia

✍ Breccia, Massimo; Alimena, Giuliana 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 309 KB

The Achievement of a 3-Month Complete Cy

The Achievement of a 3-Month Complete Cytogenetic Response to Second-Generation Tyrosine Kinase Inhibitors Predicts Survival in Patients With Chronic Phase Chronic Myeloid Leukemia After Imatinib Failure

✍ Jabbour, Elias; Kantarjian, Hagop; Ghanem, Hady; O'Brien, Susan; Quintas-Cardama 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 305 KB